Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Nebraska State Police led a multistate training in Kearney for investigators from 11 states to learn forensic examination of commercial vehicle crash scenes. The sessions used real crash vehicles and ...

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...

Oct 22 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can cause birth defects, after it failed ...

Moderna is terminating the development of an mRNA vaccine in congenital cytomegalovirus (CMV) after it failed to show any significant benefit in a Phase III trial. Top line data from the CMVictory ...

In a thoroughly surprising announcement, World of Goo 2 is coming sometime next year, it was announced during Thursday's The Game Awards. The news comes 15 years after the original was released, so it ...

The band, which was first established in 1986, hit the road for the Summer Anthem Tour earlier this year in support of their latest EP The Goo Goo Dolls are feeling lucky to have a decades-long career ...

A key question for investors going forward will be whether Moderna’s other latent virus vaccines for Epstein-Barr and shingles can succeed after the failure of the CMV program. Moderna will no longer ...

A vaccine Moderna has long been developing for the world’s most common congenital infection has failed a Phase 3 trial. The biotechnology company said late Wednesday that the shot, dubbed mRNA-1647, ...